July 11, 2019: Seroconversion while on long-acting contraceptives; cardiovascular risk in people with HIV; suboptimal testing in high-prevalence U.S. areas; E/C/F/TAF may be suitable for PEP.
Could home-based self-swabs and mobile technology be helpful tools in the future of HIV prevention?
June 20, 2019: Housing stability and HIV viremia; how the stigma of poverty affects viral load; the best time to employ syringe services; promise for the practice of index testing.
Black men who have sex with men test in high numbers over a lifetime, but not frequently or recently.
May 30, 2019: Myocardial infarction risk among people with HIV; dolutegravir vs. efavirenz; a new way to estimate date of seroconversion; identifying people at imminent risk for disengagement from care.
Our series on mentor-mentee researchers continues with Ellen Eaton, M.D., and Kelsie Dodson, with the University of Alabama at Birmingham.
Despite their increased risk, only one-third of adolescents and young adults with known opioid use disorder were screened for hepatitis C, according to a study released at the IDWeek conference in San Francisco.
Researchers found that, although HIV testing and treatment cost money, over the long term their impact on health resulted in savings because fewer people became infected with HIV.
Ten Years After Landmark HIV Testing Guidelines, How Are We Doing? Specifically in Emergency Departments?
"A lot has changed with HIV testing since the late 1990s, most notably the landmark CDC HIV testing guidelines, issued almost exactly 10 years ago today," Paul Sax, M.D., writes.
"The big advance in moving from the 3rd to the 4th generation screening test was the addition of p24 antigen to the sensitive ELISA antibody," Paul Sax, M.D. writes. "This shortens the window period from HIV acquisition to a positive screening test b...